449 related articles for article (PubMed ID: 24753360)
1. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
2. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
3. Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy.
Son S; Shin S; Rao NV; Um W; Jeon J; Ko H; Deepagan VG; Kwon S; Lee JY; Park JH
Int J Biol Macromol; 2018 Apr; 110():406-415. PubMed ID: 29055700
[TBL] [Abstract][Full Text] [Related]
4. Carboxymethyl dextran-based hypoxia-responsive nanoparticles for doxorubicin delivery.
Son S; Rao NV; Ko H; Shin S; Jeon J; Han HS; Nguyen VQ; Thambi T; Suh YD; Park JH
Int J Biol Macromol; 2018 Apr; 110():399-405. PubMed ID: 29133095
[TBL] [Abstract][Full Text] [Related]
5. Carboxymethyl dextran-cyclodextrin conjugate as the carrier of doxorubicin.
Sivasubramanian M; Thambi T; Deepagan VG; Saravanakumar G; Ko H; Kang YM; Park JH
J Nanosci Nanotechnol; 2013 Nov; 13(11):7271-8. PubMed ID: 24245242
[TBL] [Abstract][Full Text] [Related]
6. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
[TBL] [Abstract][Full Text] [Related]
7. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
[TBL] [Abstract][Full Text] [Related]
8. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
[TBL] [Abstract][Full Text] [Related]
9. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
10. Bioreducible block copolymers based on poly(ethylene glycol) and poly(γ-benzyl L-glutamate) for intracellular delivery of camptothecin.
Thambi T; Yoon HY; Kim K; Kwon IC; Yoo CK; Park JH
Bioconjug Chem; 2011 Oct; 22(10):1924-31. PubMed ID: 21899345
[TBL] [Abstract][Full Text] [Related]
11. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
Chen W; Zou Y; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
Biomacromolecules; 2014 Mar; 15(3):900-7. PubMed ID: 24460130
[TBL] [Abstract][Full Text] [Related]
12. Preparation, drug release and cellular uptake of doxorubicin-loaded dextran-b-poly(ɛ-caprolactone) nanoparticles.
Li B; Wang Q; Wang X; Wang C; Jiang X
Carbohydr Polym; 2013 Apr; 93(2):430-7. PubMed ID: 23499079
[TBL] [Abstract][Full Text] [Related]
13. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
14. Preparation of pH-Sensitive Dextran Nanoparticle for Doxorubicin Delivery.
Wang B; Liu P; Shi B; Gao J; Gong P
J Nanosci Nanotechnol; 2015 Apr; 15(4):2613-8. PubMed ID: 26353472
[TBL] [Abstract][Full Text] [Related]
15. Bioreducible Poly(ethylene glycol)-Triphenylphosphonium Conjugate as a Bioactivable Mitochondria-Targeting Nanocarrier.
Khatun Z; Choi YS; Kim YG; Yoon K; Nurunnabi M; Li L; Lee E; Kang HC; Huh KM
Biomacromolecules; 2017 Apr; 18(4):1074-1085. PubMed ID: 28257184
[TBL] [Abstract][Full Text] [Related]
16. Bioreducible core-crosslinked hyaluronic acid micelle for targeted cancer therapy.
Han HS; Choi KY; Ko H; Jeon J; Saravanakumar G; Suh YD; Lee DS; Park JH
J Control Release; 2015 Feb; 200():158-66. PubMed ID: 25550153
[TBL] [Abstract][Full Text] [Related]
17. A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy.
Zhu Q; Jia L; Gao Z; Wang C; Jiang H; Zhang J; Dong L
Mol Pharm; 2014 Oct; 11(10):3269-78. PubMed ID: 24735448
[TBL] [Abstract][Full Text] [Related]
18. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
19. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
Yang S; Tang Z; Zhang D; Deng M; Chen X
Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
[TBL] [Abstract][Full Text] [Related]
20. Functionalizing biodegradable dextran scaffolds using living radical polymerization: new versatile nanoparticles for the delivery of therapeutic molecules.
Duong HT; Hughes F; Sagnella S; Kavallaris M; Macmillan A; Whan R; Hook J; Davis TP; Boyer C
Mol Pharm; 2012 Nov; 9(11):3046-61. PubMed ID: 23078353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
